Jane Street Group, LLC Alector, Inc. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$19.35 - $25.54 $901,710 - $1.19 Million	-46,600 Reduced 61.24%	29,500 $609,000
Q3 2021 Nov 16, 2021	BUY	$21.65 - $39.49 $807,545 - $1.47 Million	37,300 Added 96.13%	76,100 $1.74 Million
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $48,050 - $69,688	3,100 Added 8.68%	38,800 $808,000
Q1 2021 May 18, 2021	SELL	$14.84 - $22.23 $201,824 - $302,328	-13,600 Reduced 27.59%	35,700 $719,000
Q4 2020 Feb 17, 2021	BUY	$9.4 - $16.7 $463,420 - $823,310	49,300 New	49,300 $746,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.